MedTrace Logo

Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients

NCT04679272 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-03-01

No results posted yet for this study

Summary

COVID-19 is an infectious disease caused by SARS-CoV2 virus. The objective of our study is to analyze the progression and the severity of COVID-19 in patients with RA. Indeed, few data are available on this subject, and this would allow us to improve management of COVID-19 in these potential at-risk patients.

Conditions

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Padern Guillaume, physician · University Hospitals of Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-01-30
Completion
2021-02-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04679272 on ClinicalTrials.gov